ALTANA Pharma (AAA) Selects Spotfire DecisionSite For Worldwide Use In Drug Discovery Research; Licensing Agreement Will Support ALTANA Pharma AG With Guided Analytics
10/19/2005 5:12:01 PM
Spotfire Inc., a market leader in visual data analytics applications for decision-making, today announced that ALTANA Pharma AG, a leading developer and manufacturer of innovative pharmaceutical products, has selected Spotfire DecisionSite(TM) analytic software worldwide for research, lead discovery and clinical safety. ALTANA Pharma AG has signed a global licensing agreement to use of DecisionSite across the research organization from target discovery through clinical safety in 4 global locations. The company is currently using DecisionSite in functional genomics and lead discovery.
comments powered by